For many people, choosing a sunscreen is about more than just SPF. Consumers also look for products that feel comfortable on the skin, provide reliable protection and are suitable for daily use. Now, Americans may soon have access to more advanced sunscreen options after the U.S. Food and Drug Administration (FDA) approved bemotrizinol (BEMT), the first new sunscreen active ingredient approved in the country in more than two decades.

According to CNN, bemotrizinol has been widely used in Europe and Asia for years and is already found in many popular sunscreen products. One of its key advantages is its ability to provide broad-spectrum protection against both UVA and UVB rays while remaining highly stable under sunlight. Experts say these qualities have helped make many European and Asian sunscreens popular among consumers.

The FDA said studies found bemotrizinol to be safe and effective for adults and children aged six months and older. Research reviewed by the agency showed that only a small amount of the ingredient is absorbed through the skin, supporting its favorable safety profile. The approval allows manufacturers to begin incorporating the ingredient into future sunscreen formulations.

Industry experts believe the decision could encourage innovation in the U.S. sunscreen market and provide consumers with more choices. Although products containing bemotrizinol are not expected to appear immediately, people who spend time outdoors, commute daily or enjoy travel may eventually benefit from sunscreen products that offer stronger and more stable protection with a more comfortable user experience.